Arndt Vogel: New Insights Into Metachronous Colorectal Cancer Risk in Lynch Syndrome
Arndt Vogel, Head of the Visceral Oncology Center, Head of the Center for Personalized Medicine, MHH, and Senior Consultant of the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School, shared a post on X about a paper by Robert Hüneburg et al. published in Clinical Gastroenterology and Hepatology:
“Identifying risk factors for metachronous colorectal cancer in Lynch syndrome
- 852 LS carriers, 21.1% metachronous CRC
- RF: Male sex, older age, left-sided tumor and partial colectomy
- supports personalized counseling.”
Title: Identifying risk factors for metachronous colorectal cancer in Lynch syndrome
Authors: Robert Hüneburg, Karolin Weber, Stefan Aretz, Verena Steinke-Lange, Elke Holinski-Feder, Matthias Kloor, Silke Redler, Deepak B. Vangala, Evelin Schröck, Andreas Block, Tim Ripperger, Katrin van Beekum, Alexander Link, Christopher Schroeder, Christoph Engel, Jacob Nattermann
You can read the Full Article in Clinical Gastroenterology and Hepatology.
More posts featuring Arndt Vogel on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023